THURSDAY, Oct. 22, 2020 (HealthDay News) — For moderately ill hospitalized patients with COVID-19, tocilizumab is not effective for preventing intubation or death, according to a study published online Oct. 21 in the New England Journal of Medicine. John H. Stone, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues conducted a randomized trial...